EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation

Pablo Juanes-Velasco iD, Carlota Arias-Hidalgo iD, Marina L García-Vaquero, Janet Sotolongo-Ravelo iD, Teresa Paíno iD, Quentin Lécrevisse iD, Alicia Landeira-Viñuela, Rafael Góngora iD, Ángela-Patricia Hernández iD, Manuel Fuentes iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25179564 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Pablo Juanes-Velasco und 9 weiteren Autor:innen. Beteiligte Einrichtung: Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of …. Hauptthemen laut MEDLINE: Peptides, Proteomics, Tandem Mass Spectrometry. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III (ISCIII), European Union, Fondos FEDER (EU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunopeptidomics is the area of knowledge focused on the study of peptides assembled in the major histocompatibility complex (MHC), or human leukocyte antigen (HLA) in humans, which could activate the immune response via specific and selective T cell recognition. Advances in high-sensitivity mass spectrometry have enabled the detailed identification and quantification of the immunopeptidome, significantly impacting fields like oncology, infections, and autoimmune diseases. Current immunopeptidomics approaches primarily focus on workflows to identify immunopeptides from HLA molecules, requiring the isolation of the HLA from relevant cells or tissues. Common critical steps in these workflows, such as cell lysis, HLA immunoenrichment, and peptide isolation, significantly influence outcomes. A systematic evaluation of these steps led to the creation of an ‘Immunopeptidome Score’ to enhance the reproducibility and robustness of these workflows. This score, derived from LC-MS/MS datasets (ProteomeXchange identifier PXD038165), in combination with available information from public databases, aids in optimizing the immunopeptidome characterization process. The ‘Immunopeptidome Score’ has been applied in a systematic analysis of protein extraction, HLA immunoprecipitation, and peptide recovery yields across several tumor cell lines enabling the selection of peptides with optimal features and, therefore, the identification of potential biomarker and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PeptidesProteomicsTandem Mass SpectrometryHumansHLA AntigensChromatography, LiquidCell Line, TumorProteomeImmunoprecipitation

Stichwörter der Autor:innen

HLALC-MS/MSMHCimmunopeptidomeimmunopeptidomics

Substanzen

PeptidesHLA AntigensProteome

Autor:innen und Institutionen

  • Translational and Clinical Research Program, Cancer Research Center (IBMCC, CSIC-University of Salamanca), Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca (Universidad de Salamanca), 37008 Sa…
  • Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.
  • Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Oncohematology Group, Cancer Research Center (IBMCC/CSIC/USAL/IBSAL), 37007 Salamanca, Spain.
  • Department of Physiology and Pharmacology, University of Salamanca, 37007 Salamanca, Spain.
  • Department of Pharmaceutical Sciences, Organic Chemistry, Faculty of Pharmacy, University of Salamanca, CIETUS, IBSAL, 37007 Salamanca, Spain.

ORCID-Profile: Pablo Juanes-Velasco, Carlota Arias-Hidalgo, Janet Sotolongo-Ravelo, Teresa Paíno, Quentin Lécrevisse, Rafael Góngora, Ángela-Patricia Hernández, Manuel Fuentes

Förderung

  • Instituto de Salud Carlos III (ISCIII)
  • European Union
  • Fondos FEDER (EU)
  • Junta Castilla-León
  • ISCIII and FEDER
  • Programa Estratégico Instituto de Biología y Genética Molecular (IBGM Junta de Castilla y León. Ref. CCVC8485)
  • Junta de Castilla y León (Proyectos COVID 07.04.467B04.74011.0)
  • the European Commission–NextGenerationEU (Regulation EU 2020/2094)

Zitieren

APA

Juanes-Velasco, P., Arias-Hidalgo, C., García-Vaquero, M. L., Sotolongo-Ravelo, J., Paíno, T., Lécrevisse, Q., Landeira-Viñuela, A., Góngora, R., Hernández, Á. P., & Fuentes, M. (2024). Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25179564

Vancouver

Juanes-Velasco P, Arias-Hidalgo C, García-Vaquero ML, Sotolongo-Ravelo J, Paíno T, Lécrevisse Q, et al. Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25179564

BibTeX
@article{JuanesVelasco2024,
  author = {Juanes-Velasco, Pablo and Arias-Hidalgo, Carlota and García-Vaquero, Marina L and Sotolongo-Ravelo, Janet and Paíno, Teresa and Lécrevisse, Quentin and Landeira-Viñuela, Alicia and Góngora, Rafael and Hernández, Ángela-Patricia and Fuentes, Manuel},
  title = {Crucial Parameters for Immunopeptidome Characterization: A Systematic Evaluation},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25179564}
}
Kostenlos starten →